Kyntra Bio KYNB
NASDAQ KYNB
$7.52 +0.20 (+2.73%)
At close: Aug 21, 2026 · 4:00 PM EDT

Kyntra Bio (KYNB) Sales of Property, Plant and Equipment (2017 - 2024)

Kyntra Bio (KYNB) Sales of Property, Plant and Equipment (2017 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.85 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 698,426.11
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Kyntra Bio 30.42 Mn 30.42 Mn 1.47 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 206,000.00
Dec 31, 2024 206,000.00
Sep 30, 2024 837,000.00
Sep 30, 2024 837,000.00
Dec 31, 2022 -2,000.00
Dec 31, 2022 -2,000.00
Sep 30, 2022 2,000.00
Sep 30, 2022 2,000.00
Dec 31, 2019 7,000.00
Dec 31, 2019 7,000.00
Jun 30, 2018 184,000.00
Jun 30, 2018 184,000.00
Mar 31, 2017 5,000.00
Mar 31, 2017 5,000.00